Burgstadt, Germany

Markus Winkenbach

This inventor holds 6 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2011-2015.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 85(Granted Patents)


Location History:

  • Burstadt, DE (2011 - 2012)
  • Bürstadt, DE (2013)
  • Buerstadt, DE (2011 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Markus Winkenbach: Innovating in Diagnostics

Introduction

Markus Winkenbach, an accomplished inventor based in Burstadt, Germany, has made significant contributions to the field of diagnostics through his innovative designs. With a total of six patents to his name, he is known for his commitment to advancing healthcare technology.

Latest Patents

Winkenbach’s recent work includes a notable patent for a container that showcases his inventive approach in the healthcare industry. His designs focus on enhancing the efficiency and reliability of diagnostic processes, reflecting his dedication to improving patient care.

Career Highlights

Markus currently works at Roche Diagnostics Operations, Inc., a leading company in the field of healthcare solutions. His role at Roche allows him to collaborate on developing cutting-edge diagnostic tools and technologies that have the potential to transform medical practices.

Collaborations

Throughout his career, Winkenbach has collaborated with esteemed colleagues, including Gottfried Senftner and Stephan Sattler. These partnerships have allowed for the exchange of innovative ideas, contributing to the successful development of several groundbreaking patents.

Conclusion

Markus Winkenbach stands out as a dedicated inventor within the diagnostics field. His impressive portfolio of patents and collaborations showcases his commitment to innovation, paving the way for advancements that will benefit the healthcare industry and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…